Elevated cerebrospinal fluid IgA in humans and rats is not associated with secretory component

A H Woo1, H F Cserr, P M Knopf

  • 1Section of Molecular, Cellular, and Developmental Biology, Brown University, Providence, RI 02912.

Insights

The study found no evidence of a secretory immunoglobulin A (IgA) system at central nervous system (CNS) boundaries. Elevated IgA in cerebrospinal fluid (CSF) is likely due to local immune cell production within the CNS.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Cerebrospinal Fluid Analysis

Background:

  • Immunoglobulin A (IgA) transport across mucosal barriers involves secretory component (SC).
  • The presence and mechanism of IgA transport at central nervous system (CNS) boundaries are not well understood.
  • Neuroinflammatory diseases can affect the CNS environment and immune responses.

Purpose of the Study:

  • To investigate whether IgA is transported via a secretory component-mediated process at CNS boundaries.
  • To determine the source of elevated IgA in cerebrospinal fluid (CSF) during CNS neuroinflammatory conditions.

Main Methods:

  • Analysis of CSF and serum IgA and SC levels in patients with CNS neuroinflammatory disease.
  • Microinfusion of inactivated lymphocytic choriomeningitis virus into the CSF of a rat model with intact brain barriers.
  • Quantification of IgA and SC in rat CSF, bile, and semen.

Main Results:

  • Elevated CSF IgA was detected in a subset of patients with CNS neuroinflammatory disease, but significant SC levels were absent.
  • In the rat model, elevated CSF IgA was observed after viral microinfusion, but the proportion of secretory IgA remained insignificant.
  • CSF IgA levels in rats were disproportionately low compared to exocrine fluids like bile and semen.

Conclusions:

  • A secretory IgA immune system does not appear to operate at CNS boundaries.
  • Elevated IgA in CSF during neuroinflammation is likely a result of intrathecal synthesis (production within the CNS).
  • This finding suggests that increased CSF IgA in CNS diseases originates from local B-cell activation and antibody production.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...